vimarsana.com
Home
Live Updates
Kintor Pharma Announces Completion of First Patient Enrollment in Long-term Safety Phase III Trial of KX-826 for Treatment of AGA : vimarsana.com
Kintor Pharma Announces Completion of First Patient Enrollment in Long-term Safety Phase III Trial of KX-826 for Treatment of AGA
/PRNewswire/ -- Kintor Pharmaceutical Limited ("Kintor Pharma", HKEX: 9939), a clinical-stage biotechnology company developing innovative small molecules and...
Related Keywords
United States ,
China ,
Suzhou ,
Jiangsu ,
Peking ,
Beijing ,
Kintor Pharma ,
Jianzhong Zhang ,
Prnewswire Kintor Pharmaceutical Limited Pharma ,
Kintor Pharmaceutical ,
University People Hospital ,
China National Medical Products Administration ,
Pharmaceutical Limited ,
Long Term Safety Trial ,
Professor Jianzhong Zhang ,
Peking University People ,
Long Term Safety ,
vimarsana.com © 2020. All Rights Reserved.